Go Back

James F. Winschel

Non-Executive Director

James Winschel

Appointment to the Board:

James (Jim) Winschel was appointed to the hVIVO Board as a Non-Executive Director in October 2014 and is Chairman of the Audit Committee.

Experience and expertise

Following thirteen years as Senior Vice President and Chief Financial
Officer of PAREXEL International Corporation (NASDAQ: PRXL), a leading biopharmaceutical services organization providing comprehensive drug development, consulting, medical communications, and technology services and solutions to the biopharmaceutical industry in over 100 countries, Jim was appointed Executive Vice President of PAREXEL in September 2013 until he retired in June 2014. As CFO of PAREXEL, Jim was responsible for directing all financial activities, during a period when PAREXEL’s revenue grew by $1.5 billion, backlog increased by $4.5 billion and PAREXEL’s market capitalisation increased from $225 million to $2.8 billion. The Company was recently sold to private equity for $4.5 billion. Earlier in his career, Jim spent five years at BTM Capital Corporation, a Bank of Tokyo-Mitsubishi Ltd. subsidiary, initially as Executive Vice President and Chief Financial Officer for three years from 1995 before being promoted to President, U.B. Vehicle Leasing, Inc. until 2000. Prior to these roles, he was Vice President – Finance, Physician Services Division at Caremark International, Inc. for two years from 1993 and spent the previous four years at Whirlpool Financial Corporation (“WFC”), both as the Vice President and Managing Director, Commercial Financing Division and prior to that as the Vice President and Chief Financial Officer. Jim worked for five years in various roles at General Electric Capital Corporation, in the Transportation and Industrial Financing Division and prior to that at General Electric Company for eleven years. Jim holds an MBA in Accounting and a BSc in Finance from Syracuse University in the USA.

Current external appointments

Jim is CFO of Hamlin Scientific Corporation in Boston, MA and CFO of Vivtex Corporation in Cambridge, MA.